IBDEI1FS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23989,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,23989,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23989,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,23990,0)
 ;;=I30.0^^116^1175^3
 ;;^UTILITY(U,$J,358.3,23990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23990,1,3,0)
 ;;=3^Pericarditis,idiopath,acute,nonspec
 ;;^UTILITY(U,$J,358.3,23990,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,23990,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,23991,0)
 ;;=I73.9^^116^1175^4
 ;;^UTILITY(U,$J,358.3,23991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23991,1,3,0)
 ;;=3^Peripheral vascular disease, unspec
 ;;^UTILITY(U,$J,358.3,23991,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,23991,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,23992,0)
 ;;=F60.89^^116^1175^5
 ;;^UTILITY(U,$J,358.3,23992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23992,1,3,0)
 ;;=3^Personality disorders,oth,spec
 ;;^UTILITY(U,$J,358.3,23992,1,4,0)
 ;;=4^F60.89
 ;;^UTILITY(U,$J,358.3,23992,2)
 ;;=^5003638
 ;;^UTILITY(U,$J,358.3,23993,0)
 ;;=I80.3^^116^1175^7
 ;;^UTILITY(U,$J,358.3,23993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23993,1,3,0)
 ;;=3^Phlebitis & thrombophlbts of low extrmties, unspec
 ;;^UTILITY(U,$J,358.3,23993,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,23993,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,23994,0)
 ;;=R09.1^^116^1175^9
 ;;^UTILITY(U,$J,358.3,23994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23994,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,23994,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,23994,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,23995,0)
 ;;=J91.8^^116^1175^8
 ;;^UTILITY(U,$J,358.3,23995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23995,1,3,0)
 ;;=3^Pleural effus in oth cond clsfd elsewhere
 ;;^UTILITY(U,$J,358.3,23995,1,4,0)
 ;;=4^J91.8
 ;;^UTILITY(U,$J,358.3,23995,2)
 ;;=^5008311
 ;;^UTILITY(U,$J,358.3,23996,0)
 ;;=J18.9^^116^1175^10
 ;;^UTILITY(U,$J,358.3,23996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23996,1,3,0)
 ;;=3^Pneumonia, unspec organism
 ;;^UTILITY(U,$J,358.3,23996,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,23996,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,23997,0)
 ;;=I49.3^^116^1175^12
 ;;^UTILITY(U,$J,358.3,23997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23997,1,3,0)
 ;;=3^Premature ventricular depolarization
 ;;^UTILITY(U,$J,358.3,23997,1,4,0)
 ;;=4^I49.3
 ;;^UTILITY(U,$J,358.3,23997,2)
 ;;=^5007233
 ;;^UTILITY(U,$J,358.3,23998,0)
 ;;=L40.4^^116^1175^14
 ;;^UTILITY(U,$J,358.3,23998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23998,1,3,0)
 ;;=3^Psoriasis Guttate
 ;;^UTILITY(U,$J,358.3,23998,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,23998,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,23999,0)
 ;;=L40.1^^116^1175^16
 ;;^UTILITY(U,$J,358.3,23999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23999,1,3,0)
 ;;=3^Psoriasis, generalized pustular
 ;;^UTILITY(U,$J,358.3,23999,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,23999,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,24000,0)
 ;;=L40.0^^116^1175^15
 ;;^UTILITY(U,$J,358.3,24000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24000,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,24000,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,24000,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,24001,0)
 ;;=L40.8^^116^1175^17
 ;;^UTILITY(U,$J,358.3,24001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24001,1,3,0)
 ;;=3^Psoriasis, other
 ;;^UTILITY(U,$J,358.3,24001,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,24001,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,24002,0)
 ;;=L29.9^^116^1175^13
 ;;^UTILITY(U,$J,358.3,24002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24002,1,3,0)
 ;;=3^Pruritus, unspec
